Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
BAYRY BAYER AG
14.510
-0.030-0.21%
YOY
Do not show
Hide blank lines
(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31(Q4)2021/12/31
Total revenue
18.10% 12.82B 18.75% 14.64B 6.48% 44.08B 11.24% 11.12B
Operating revenue
18.10% 12.82B 18.75% 14.64B 6.48% 44.08B 11.24% 11.12B
Cost of revenue
24.95% 5.68B 10.17% 5.18B -12.13% 16.82B 0.44% 3.69B
Gross profit
13.17% 7.14B 24.02% 9.46B 22.47% 27.27B 17.50% 7.43B
Operating expense
-18.85% 6.97B 15.48% 5.25B -11.40% 20.36B 117.44% 1.86B
Selling and administrative expenses
19.35% 4.47B 12.04% 3.95B -3.81% 15.33B 22.92% 4.29B
-Selling and marketing expense
26.05% 3.74B 14.07% 3.28B -5.29% 12.36B 23.98% 3.51B
-General and administrative expense
-6.00% 736M 2.96% 661M 2.88% 2.96B 18.37% 786M
Research and development costs
17.70% 1.93B 21.37% 1.45B -24.05% 5.41B -21.61% 1.01B
Other operating expenses
-63.91% 1.35B 102.81% 361M -31.60% 316M 75.56% -3.95B
Operating profit
107.41% 169M 36.62% 4.21B 1,067.65% 6.91B -67.14% 5.58B
Net non-operating interest income expense
-220.10% -653M -45.96% -470M 25.65% -945M 71.00% -116M
Non-operating interest income
-81.55% 50M -31.63% 67M 71.29% 346M 80.59% -53M
Non-operating interest expense
48.00% 703M 27.86% 537M -15.60% 1.35B -52.40% 119M
Total other finance cost
-- -- -- -- 54.47% -56M -- --
Other net income (expense)
Special income (charges)
-- -- -- -- 77.30% -3.52B -- --
-Less:Other special charges
-- -- -- -- -73.71% 3.47B -- --
-Write off
-- -- -- -- -6.25% 45M -- --
Income before tax
78.03% -523M 36.09% 3.72B 111.86% 2.05B 9.03% 1.5B
Income tax
-350.00% -234M -33.64% 428M 160.63% 1.02B -66.87% 327M
Net income
87.59% -289M 57.61% 3.29B 109.75% 1.02B 276.21% 1.17B
Net income continuous Operations
87.59% -289M 57.61% 3.29B 106.57% 1.02B 203.11% 1.17B
Minority interest income
28.57% 9M 200.00% 3M 175.00% 22M 200.00% 9M
Net income attributable to the parent company
87.24% -298M 57.54% 3.29B 109.53% 1B 276.95% 1.16B
Preferred stock dividends
Other preferred stock dividends
0 0 0 0
Net income attributable to common stockholders
87.24% -298M 57.54% 3.29B 109.53% 1B 276.95% 1.16B
Basic earnings per share
87.39% -0.075 57.28% 0.8375 109.55% 0.255 268.75% 0.295
Diluted earnings per share
87.39% -0.075 57.28% 0.8375 109.55% 0.255 268.75% 0.295
Dividend per share
1.86% 0.4988 0 -30.16% 0.4896 0
Currency Unit
EUREUREUREUR

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials. It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro. The Pharmaceuticals segment engages in the development, production and marketing of prescription products for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology and ophthalmology; diagnostic imaging equipment and the necessary contrast agents. The Consumer Health segment manufactures and markets products in the dermatology, dietary supplement, analgesic, gastrointestinal, cold, allergy, sinus and flu, foot care and sun protection categories. The CropScience segment includes seeds and plant traits, crop protection and nonagricultural pest control. The Animal Health segment offers prescription and nonprescription veterinary products. The Covestro segment provides raw materials for polyurethanes; polycarbonate granules and sheets; raw materials for coatings, adhesives and sealants; and by-products of polyether production and of chlorine production and use. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.
CEO: --
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist